Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma
17/08/2026 13:33
BRIEF-Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma Evaxion A/S EVAX.O:
EVAXION A/S - EXPANDS PIPELINE OF CANCER VACCINE PROGRAMS WITH EVX-05 AGAINST BRAIN CANCER GLIOBLASTOMA
EVAXION A/S: COSTS RELATED TO EVX-05 CAPTURED WITHIN CO'S EXISTING BUDGETS NOT IMPACTING ON CASH RUNWAY, WHICH CONTINUES TO STRETCH INTO H2'2027
Source text: ID:nGNX5Nmy2d
Further company coverage: EVAX.O
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma